Cargando…

Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus

Type I and type III interferons (IFNs) share several properties in common, including the induction of signaling pathways, the activation of gene transcripts, and immune responses, against viral infection. Recent advances in the understanding of the molecular basis of innate and adaptive immunity hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chyuan, I-Tsu, Tzeng, Hong-Tai, Chen, Ji-Yih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769759/ https://www.ncbi.nlm.nih.gov/pubmed/31450787 http://dx.doi.org/10.3390/cells8090963

Ejemplares similares

Systemic lupus erythematosus and the type I interferon system
por: Rönnblom, Lars, et al.
Publicado: (2003)

The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus
por: Fan, Wei, et al.
Publicado: (2023)

A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
por: Oon, Shereen, et al.
Publicado: (2019)

Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes
por: Karageorgas, Theophanis P., et al.
Publicado: (2011)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
por: Oke, Vilija, et al.
Publicado: (2019)

Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease
por: Kuriyama, Yuko, et al.
Publicado: (2021)

Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
por: Shrivastav, Meena, et al.
Publicado: (2013)

A new tool for detection of type I interferon activation in systemic lupus erythematosus
por: Kirou, Kyriakos A, et al.
Publicado: (2010)

Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus
por: Thanarajasingam, Uma, et al.
Publicado: (2019)

Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
por: Smith, Michael A., et al.
Publicado: (2020)

Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside
por: Sim, Tao Ming, et al.
Publicado: (2022)

Targeting type I interferons in systemic lupus erythematous
por: Bruera, Sebastian, et al.
Publicado: (2023)

Differential Regulation of Type I and Type III Interferon Signaling
por: Stanifer, Megan L., et al.
Publicado: (2019)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017)

A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus
por: Kim, Ji-Min, et al.
Publicado: (2015)

Type I and type III interferon in opposition?
por: Park, Matthew D.
Publicado: (2020)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’
por: Dolff, Sebastian, et al.
Publicado: (2014)

Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2015)

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2017)

Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19
por: Nasser, Nourhane, et al.
Publicado: (2021)

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
por: Northcott, Melissa, et al.
Publicado: (2022)

Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
por: Somers, Emily C., et al.
Publicado: (2012)

Type I interferons affect the metabolic fitness of CD8(+) T cells from patients with systemic lupus erythematosus
por: Buang, Norzawani, et al.
Publicado: (2021)

Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Decoding type I and III interferon signalling during viral infection
por: Mesev, Emily V., et al.
Publicado: (2019)

Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons
por: Rabin, Ronald L., et al.
Publicado: (2021)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway
por: Yeung, Kit San, et al.
Publicado: (2017)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply
por: Brkic, Zana, et al.
Publicado: (2014)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
por: Park, Annsea, et al.
Publicado: (2020)

The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons
por: Dussurget, Olivier, et al.
Publicado: (2014)

Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature
por: Hammond, Edward R, et al.
Publicado: (2020)

Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
por: Chyuan, I-Tsu, et al.
Publicado: (2018)

Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus
por: Nielsen, Christoffer T, et al.
Publicado: (2014)

Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus Erythematosus
por: Demers-Mathieu, Veronique
Publicado: (2023)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2018)

Systemic Lupus Erythematosus and Risk of Dry Eye Disease and Corneal Surface Damage: A Population-Based Cohort Study
por: Tseng, Ching-Han, et al.
Publicado: (2023)

Editorial: Type I and Type III Interferon Immune Responses in Asthma
por: Finotto, Susetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n3i48uiuclk3i3oe54vh2t8eh